New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2013
11:36 EDTEBIX, STD, SD, RVBD, QCOROptions with decreasing implied volatility: EBIX STD SD RVBD QCOR
News For EBIX;STD;SD;RVBD;QCOR From The Last 14 Days
Check below for free stories on EBIX;STD;SD;RVBD;QCOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 16, 2014
10:35 EDTQCOROptions with decreasing implied volatility
Subscribe for More Information
July 15, 2014
10:48 EDTRVBDOptions with increasing implied volatility: GLUU KORS RVBD HSH
July 14, 2014
16:30 EDTRVBDOn The Fly: Closing Wrap
Subscribe for More Information
15:09 EDTQCORQuestcor rises after S-4 effective, interest from other suitors disclosed
Subscribe for More Information
13:11 EDTRVBDRiverbed downgraded to Perform at Oppenheimer
Subscribe for More Information
13:06 EDTRVBDRiverbed downgraded to Perform from Outperform at Oppenheimer
Subscribe for More Information
12:21 EDTRVBDOn The Fly: Midday Wrap
Subscribe for More Information
10:59 EDTRVBDElliot reaffirms $21 Riverbed bid following Q2 warning
Subscribe for More Information
10:54 EDTRVBDRiverbed Q2 miss strengthens Elliot case, says Wells Fargo
Subscribe for More Information
10:03 EDTSDOptions with increasing implied volatility: GNC SD MDLZ ETP
10:02 EDTRVBDElliott Management reaffirms $21 per share cash bid for Riverbed
Subscribe for More Information
09:16 EDTRVBDOn The Fly: Pre-market Movers
HIGHER: Citigroup (C), up 3.6% after reporting better than expected Q2 results, announcing $7B settlement with DOJ and FDIC... Apple (AAPL), up 0.7% after Barclays upgrades stock to Overweight, Morgan Stanley raises Apple estimates above consensus... Shire (SHPG), up 1.6% after receiving revised proposal from AbbVie (ABBV) of GPB 53.20 per share, which it says it would be willing to recommend to Shire shareholders. AbbVie is down 2.8% after the news... Mylan (MYL), up 4% after acquiring Abbott's (ABT) non-U.S. developed markets specialty and branded generics business in all-stock transaction valued at about $5.3B. Abbott up 1.6% after the news... Progenics (PGNX), up 13% after FDA says RELISTOR can be approved on data submitted in sNDA... Exelixis (EXEL), up 13% after announcing coBRIM Phase 3 trial met primary endpoint... URS (URS) up 8% after acquired by AECOM Technology (ACM) for $56.31 per share. AECOM shares alos up 2% after deal announcement... Whiting Petroleum (WLL), up 4.5% after agreeing to acquire Kodiak Oil & Gas (KOG) in a $6B transaction. Kodiak Oil & Gas up 3%... Kandi Technologies (KNDI), up 11% after announcing JV's sale of 4,114 EVs in Q2. LOWER: Riverbed (RVBD), down 4.5% after saying it sees its Q2 adjusted EPS at low end of 26c-28c range... Harmonic (HLIT), down 13% after reporting preliminary Q2 earnings results.. EBay (EBAY), down 0.5% after downgraded at Pacific Crest, confirming partnership plans with Sotheby's (BID).
09:14 EDTRVBDRiverbed falls on Q2 EPS view, levels to watch
Subscribe for More Information
08:32 EDTRVBDRiverbed CEO says Q2 sales 'below expectations'
Subscribe for More Information
08:31 EDTRVBDRiverbed sees Q2 adjusted EPS at low end of 26c-28c range, consensus 27c
Cuts Q2 adjusted revenue view to $264M-$265M from $274M-$280M, consensus $277.42M. “Second quarter sales were below our expectations, principally in North America as we experienced longer sales cycles on some of our larger and more complex deals. We have carefully reviewed our opportunities and prospects for the remainder of the year and continue to have confidence in our ability to grow the business and deliver targeted earnings performance,” said Jerry M. Kennelly, chairman and CEO, Riverbed. “During the quarter, we continued to prudently manage expenses and focus on achieving operating leverage, as demonstrated by our solid EPS performance within our guided range.”
07:04 EDTQCORMallinckrodt and Questcor update transaction
Mallinckrodt (MNK) and Questcor (QCOR) announced that the registration statement on Form S-4 filed with the SEC by Mallinckrodt on May 16 and amended on July 11 which includes a joint proxy statement of Mallinckrodt and Questcor that also constitutes a prospectus of Mallinckrodt, was declared effective on July 11. The companies have also each scheduled shareholder meetings on August 14 for shareholders of record on July 9 to consider (i) in the case of Mallinckrodt, its proposal to issue its ordinary shares in connection with its proposed acquisition of Questcor and (ii) in the case of Questcor, approval of the merger agreement with Mallinckrodt and related matters. The transaction is currently expected to be completed in August.
July 11, 2014
11:31 EDTSDOptions with increasing implied volatility
Options with increasing implied volatility: INO AEGR UBNT INVN WTW OREX GNC CREE SD SAN
09:09 EDTQCOROn The Fly: Pre-market Movers
Subscribe for More Information
06:39 EDTQCORQuestcor reports Acthar adverse effects data, NY Times says
The number of patients who reported an adverse effect last year while taking Questcor's (QCOR) Acthar drug amounted to almost 5% of prescriptions dispensed, the company stated in a regulatory filing released yesterday, according to The New York Times. The filing marked the first time that the company has disclosed any difficulties experienced by Acthar patients, the newspaper added. Questcor has agreed to be bought by Mallinckrodt (MNK). Reference Link
July 10, 2014
11:09 EDTSDOptions with increasing implied volatility
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use